or
forgot password

    • cancer clinical trials in hazard, KY

    • Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Hazard, Kentucky
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Kentucky Cancer Center
    Hazard, Kentucky 41701
    Non-small Cell Lung Cancer
    Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning
    Hazard ARH Regional Medical Center
    Hazard, Kentucky 41702
    Lung Cancer
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    Kentucky Lung Clinic
    Hazard, Kentucky 41701
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
    Kenthucky Cancer Clinic
    Hazard, Kentucky 41701
    Pancreatic Cancer, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Kentucky Cancer Center
    Hazard, Kentucky 41701
    Adenocarcinoma of the Lung
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Kentucky Cancer Clinic - Hazard
    Hazard, Kentucky 41701
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    North Shore Medical Center
    Hazard, Kentucky
    Chemotherapy-Induced Nausea and Vomiting